TAREK ABDALLA
Prescription History 1043771421
Internal Medicine - Infectious Disease in Birmingham, AL
Medicare Part D Prescription History
Explore the verified Medicare Part D prescription history, volume metrics, and calculated drug costs for TAREK ABDALLA, an active Infectious Disease specialist practicing in Birmingham, AL. Our medical registry currently tracks 6 unique pharmaceutical formulations prescribed by this provider, representing an estimated volume of 119 documented patient claims. Among these therapy options, the most frequently utilized medication is Doxycycline Hyclate, which accounts for 28 claims alone. Use the table below to sort by claims, cost, or utilization compared with the state average; select any medication for its full profile.
| Medication | Prescriptions (2024)Rx (2024) | Avg Cost per FillCost / Fill | Vs. Other AL PrescribersVs. AL Avg |
|---|---|---|---|
| Doxycycline Hyclate | 28 | $48.93 | ▼ Less than typical |
About Doxycycline Hyclate: This medication is used to treat a wide variety of bacterial infections, including those that cause acne. Show more ▾ This medication is also used to prevent malaria. This medication is known as a tetracycline antibiotic. It works by stopping the growth of bacteria. This antibiotic treats only bacterial infections. It will not work for viral infections (such as common cold, flu). Using any antibiotic when it is not needed can cause it to not work for future infections. A synthetic tetracycline derivative with similar antimicrobial activity. In 2024, this provider wrote 28 Medicare prescriptions for Doxycycline Hyclate, about 65% of the volume of the typical Alabama prescriber of this medication (43.3). Medicare paid an average of $48.93 per fill, versus $13.14 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average AL prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 42.4 30-Day Fills standardized to 30-day supplies 1,249 Days of Medication total across all patients in 2024 | |||
| BiktarvyBictegrav/Emtricit/Tenofov Ala | 24 | $4,227.26 | ▼ Less than typical |
About Biktarvy: This combination product is used by itself to help control HIV infection. Show more ▾ It helps to decrease the amount of HIV in your body so your immune system can work better. This lowers your chance of getting HIV complications (such as new infections, cancer) and improves your quality of life. This product is a combination of 3 different drugs: bictegravir, emtricitabine, and tenofovir alafenamide. Bictegravir is called an integrase strand transfer inhibitor-INSTI. Emtricitabine is called a nucleoside reverse transcriptase inhibitor, while tenofovir alafenamide is called a nucleotide reverse transcriptase inhibitor. Emtricitabine and tenofovir alafenamide are often called NRTIs. Bictegravir/emtricitabine/tenofovir alafenamide is not a cure for HIV infection. To decrease your risk of spreading HIV disease to others, continue to take all HIV medications exactly as prescribed by your doctor. Use an effective barrier method (latex or polyurethane condoms/dental dams) during sexual activity as directed by your doctor. Do not share personal items (such as needles/syringes, toothbrushes, and razors) that may have contacted blood or other body fluids. Consult your doctor or pharmacist for more details. In 2024, this provider wrote 24 Medicare prescriptions for Biktarvy, about a quarter of the volume of the typical Alabama prescriber of this medication (96.5). Medicare paid an average of $4,227.26 per fill, versus $4,017.33 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average AL prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 28 30-Day Fills standardized to 30-day supplies 840 Days of Medication total across all patients in 2024 | |||
| Cefadroxil | 22 | $86.70 | ▼ Less than typical |
About Cefadroxil: This medication is used to treat a wide variety of bacterial infections. Show more ▾ It belongs to a class of drugs known as cephalosporin antibiotics. It works by stopping the growth of bacteria. This antibiotic treats only bacterial infections. It will not work for viral infections (such as common cold, flu). Using any antibiotic when it is not needed can cause it to not work for future infections. Long-acting, broad-spectrum, water-soluble, CEPHALEXIN derivative. In 2024, this provider wrote 22 Medicare prescriptions for Cefadroxil, about a third of the volume of the typical Alabama prescriber of this medication (58.8). Medicare paid an average of $86.70 per fill, versus $12.29 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average AL prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 28.9 30-Day Fills standardized to 30-day supplies 863 Days of Medication total across all patients in 2024 | |||
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 17 | $27.77 | ▼ Less than typical |
About Amoxicillin-Clavulanate Potass: Amoxicillin/clavulanic acid is a combination penicillin-type antibiotic used to treat a wide variety of bacterial infections. Show more ▾ It works by stopping the growth of bacteria. This antibiotic treats only bacterial infections. It will not work for viral infections (such as common cold, flu). Using any antibiotic when it is not needed can cause it to not work for future infections. In 2024, this provider wrote 17 Medicare prescriptions for Amoxicillin-Clavulanate Potass, about half the volume of the typical Alabama prescriber of this medication (33). Medicare paid an average of $27.77 per fill, versus $11.24 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average AL prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 17.4 30-Day Fills standardized to 30-day supplies 506 Days of Medication total across all patients in 2024 | |||
| Amoxicillin | 16 | $29.43 | ▼ Less than typical |
About Amoxicillin: Amoxicillin is used to treat a wide variety of bacterial infections. Show more ▾ This medication is a penicillin-type antibiotic. It works by stopping the growth of bacteria. This antibiotic treats only bacterial infections. It will not work for viral infections (such as common cold, flu). Using any antibiotic when it is not needed can cause it to not work for future infections. Amoxicillin is also used with other medications to treat stomach/intestinal ulcers caused by the bacteria H. pylori and to prevent the ulcers from returning. A broad-spectrum semisynthetic antibiotic similar to AMPICILLIN except that its resistance to gastric acid permits higher serum levels with oral administration. In 2024, this provider wrote 16 Medicare prescriptions for Amoxicillin, about a third of the volume of the typical Alabama prescriber of this medication (48.7). Medicare paid an average of $29.43 per fill, versus $3.20 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average AL prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 22.4 30-Day Fills standardized to 30-day supplies 672 Days of Medication total across all patients in 2024 | |||
| Pantoprazole Sodium | 12 | $2.42▼ below AL avg | ▼ Less than typical |
About Pantoprazole Sodium: Pantoprazole is used to treat certain stomach and esophagus problems (such as acid reflux). Show more ▾ It works by decreasing the amount of acid your stomach makes. This medication relieves symptoms such as heartburn, difficulty swallowing, and cough. It helps heal acid damage to the stomach and esophagus, helps prevent ulcers, and may help prevent cancer of the esophagus. Pantoprazole belongs to a class of drugs known as proton pump inhibitors (PPIs). 2-pyridinylmethylsulfinylbenzimidazole proton pump inhibitor that is used in the treatment of GASTROESOPHAGEAL REFLUX and PEPTIC ULCER. In 2024, this provider wrote 12 Medicare prescriptions for Pantoprazole Sodium, about 9% of the volume of the typical Alabama prescriber of this medication (128.1). Medicare paid an average of $2.42 per fill, versus $12.19 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average AL prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the AL average for this medication. 12 30-Day Fills standardized to 30-day supplies 360 Days of Medication total across all patients in 2024 | |||
About this data. The prescription history for TAREK ABDALLA is compiled from the Centers for Medicare & Medicaid Services (CMS) Medicare Part D Prescriber Public Use File for calendar year 2024, the most recent federal release. Figures cover prescriptions filled for Medicare Part D beneficiaries only; prescriptions under private insurance, Medicaid, or self-pay plans are not included. Because prescribing decisions are generally consistent across coverage types, this record offers a useful view of the overall Infectious Disease prescribing approach at this Birmingham, AL practice.
Reading the costs. Drug costs are gross amounts paid to pharmacies under Part D, including both plan and beneficiary payments. They are not the price a patient pays at the pharmacy counter. Medications with fewer than 11 claims are excluded from the federal source data, and state comparisons use the average among AL prescribers of the same medication and form, shown only when at least five prescribers contribute. Always confirm current medications and costs directly with the provider and your plan.
About the medication summaries. Drug use descriptions come from the CMS Medicare Part D Drug Spending Dashboard (2024), and substance definitions from Medical Subject Headings (MeSH) 2026, U.S. National Library of Medicine. They are summaries that do not contain all possible information about a medication and are not individual medical advice. Ask a health care professional about any medication and your specific health needs.
